Interleukin-7 (IL-7) activates phosphoinositide 3-kinase/Akt/ mammalian target of rapamycin (PI3K/Akt/mTOR) pathway, thereby mediating viability, proliferation and growth of T-cell acute lymphoblastic leukemia (T-ALL) cells. Reactive oxygen species (ROS) can be upregulated by growth factors and are known to regulate proliferation and viability. Here, we show that IL-7 upregulates ROS in T-ALL cells in a manner that is dependent on PI3K/Akt/mTOR pathway activity and that relies on both NADPH oxidase and mitochondrial respiratory chain. Conversely, IL-7-induced activation of PI3K signaling pathway requires mitochondrial respiration and ROS. We have previously shown that IL-7-mediated activation of PI3K pathway drives the upregulation of the glucose transporter Glut1, promoting glucose uptake in T-ALL cells. Using phloretin to inhibit Glut function, we demonstrate that glucose uptake is mandatory for ROS upregulation in IL-7-treated T-ALL cells, suggesting that IL-7 stimulation leads to increased ROS via PI3K pathway activation and consequent upregulation of Glut1 and glucose uptake. Overall, our data reveal the existence of a critical crosstalk between PI3K/Akt signaling pathway and ROS that is essential for IL-7-mediated T-ALL cell survival, and that may constitute a novel target for therapeutic intervention.
Introduction
Despite increasing awareness of the potential importance of microenvironmental factors for the initiation and progression of hematological malignancies, the actual relevance for and regulation of tumorigenesis by particular cues remains largely undefined. Nonetheless, several lines of evidence indicate that interleukin-7 (IL-7) has a significant role in T-cell leukemia. 1 For instance, in vitro studies have shown that IL-7 promotes survival and proliferation of T-cell acute lymphoblastic leukemia (T-ALL) cells [2] [3] [4] [5] and IL-7 transgenic mice develop lymphoid malignancies. 6, 7 The phosphoinositide 3-kinase (PI3K) signaling pathway, which regulates survival, proliferation, growth and motility, is deregulated in numerous human cancers, including myeloid leukemias 8, 9 and T-ALL. 10 Previously, we demonstrated that IL-7 relies on PI3K and its downstream target, mammalian target of rapamycin (mTOR), not only to promote proliferation and viability of T-ALL cells, but also to upregulate Glut1, increase glucose uptake and induce leukemia cell growth. 3, 5 T-ALL cells display elevated levels of reactive oxygen species (ROS). 10 ROS have been clearly implicated in malignant transformation 8, 11 and can function as second messengers. 12 Upon ligand binding, a wide variety of receptors induce the generation of intracellular ROS, such as hydrogen peroxide (H 2 O 2 ) and superoxide (O 2 K À ), 13, 14 which can reversibly inactivate phosphatase and tensin homologue and activate phosphoinositide 3-kinase (PI3K)/Akt pathway. [15] [16] [17] In this study, we have investigated the potential role of ROS in IL-7-mediated signal transduction in T-ALL cells. We observed that ROS levels in T-ALL cells were upregulated by IL-7 stimulation, and that IL-7 signaling maintained leukemia cell viability in a ROS-dependent manner. Furthermore, ROS were critical for IL-7-mediated activation of PI3K/Akt/mTOR signaling pathway, in a manner that was dependent on mitochondrial respiratory chain. Reciprocally, the PI3K/Akt/Glut axis was mandatory for IL-7-mediated sustained-ROS upregulation in T-ALL cells, which relied both on mitochondrial respiration and NADPH oxidase activity.
Materials and methods

Cells
T-ALL cells were obtained from peripheral blood and/or bone marrow of diagnostic pediatric patients with high leukemia involvement (485%) and enriched by density centrifugation over Ficoll-Paque (GE Healthcare, Carnaxide, Portugal). Normal peripheral blood mononuclear cells were isolated from peripheral blood of healthy donors. Written informed consent and Institutional Review Board approval were obtained for all sample collections. TAIL7 cells share significant similarities with primary T-ALL samples. 18 In vitro culture IL-7-deprived TAIL7 cells or primary T-ALL cells were cultured as 2 Â 10treated for 30 min with H 2 O 2 and glucose oxidase to obtain steady-state levels of H 2 O 2 , as described. 19 Cells were then washed with phosphate-buffered saline and cultured under normal conditions for 48 h. Human peripheral blood mononuclear cells were cultured for 2 days with phorbol 12-myristate 13-acetate (10 ng/ml, Sigma-Aldrich) and ionomycin (1 mg/ml, Sigma-Aldrich), then washed and grown for at least 24 h in medium supplemented with 10 U/ml rhIL-2 (Roche Molecular Biochemicals, Mannheim, Germany).
Determination of intracellular ROS levels
Cells were incubated with 10 mM dichlorofluorescein diacetate (Sigma-Aldrich) for 15 min at 37 1C, washed and analyzed by flow cytometry. Samples were acquired in a FACSCalibur flow cytometer (Becton-Dickinson, Mountain View, CA, USA) and analyzed with FlowJo software (Tree Star, Ashland, OR, USA).
Analysis of mitochondrial membrane potential
Cells were incubated with 100 nM tetramethylrhodamine ethyl ester perchlorate (Sigma-Aldrich) for 15 min at 37 1C and analyzed by flow cytometry.
Assessment of cell viability
Determination of cell viability was performed using an Annexin V-based apoptosis detection kit according to the manufacturer's instructions (R&D systems, Minneapolis, MN, USA), or assessed by cell size (FSC) versus cell complexity/granulosity (SSC) flow cytometry analysis.
Short-term signaling experiments
IL-7-deprived TAIL7 cells were washed twice with phosphatebuffered saline and incubated for the indicated periods at 37 1C with pre-warmed phosphate-buffered saline alone (unstimulated), 50 ng/ml of IL-7 or 1 mM H 2 O 2 . In defined experiments, cells were pre-incubated in RPMI with 500 mM bME for 2 h 30 min, 50 nM rotenone for 1 h or 10 mM apocynin for 1 h. Reactions were stopped by placing samples on ice. Cells were washed twice with cold phosphate-buffered saline and lysed for immunoblotting peripheral blood mononuclear cells were stimulated as previously described. 20 
Immunoblotting
Cell lysates were prepared as described. 21 Proteins were analyzed by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, blotted onto a nitrocellulose membrane (Bio-Rad, Amadora, Portugal) and probed with relevant antibodies raised against: ZAP-70 (Upstate Biotechnology, Lake Placid, NY, USA), actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and p-Akt (S473), p-GSK3b (S9), p-FOXO3a (T32) and p-S6 (S235/236) (Cell Signaling, Danvers, MA, USA). Immune complexes were detected with appropriate horseradish peroxidase-conjugated secondary antibodies.
Statistical analysis
Differences between populations were calculated using twotailed Wilcoxon signed-rank test. A P-value less than 0.05 was considered significant.
Results
IL-7 upregulates intracellular ROS in T-ALL cells
Elevated levels of ROS and downregulation of ROS scavengers and antioxidant enzymes were reported to be associated with cancer. 22 We found that primary T-ALL cells have high intracellular ROS levels that are important for leukemia maintenance. 10 As we previously demonstrated that IL-7 is critical for expansion and viability of T-ALL cells in vitro, 5 we asked whether ROS levels could be regulated by IL-7 in leukemia cells. We cultured the IL-7-dependent T-ALL cell line, TAIL7, and primary T-ALL cells, with 10 ng/ml IL-7 for 72 h and observed that IL-7-mediated signaling can upregulate the levels of intracellular ROS (Figure 1a) . To confirm that the upregulation of ROS in T-ALL cells resulted from specific IL-7 binding to the IL-7R, we used an anti-IL-7 neutralizing antibody, which reversed IL-7-mediated ROS upregulation ( Figure 1c) . Furthermore, we found that all IL-7Ra-positive samples analyzed (n ¼ 7) increased endogenous ROS levels in the presence of IL-7 (Figures 1b, c and e), whereas the only leukemia sample in our study that showed upregulation of ROS levels upon IL-7 stimulation (P ¼ 0.0156; Wilcoxon signed-rank test). Intracellular ROS levels were normalized to medium control condition and presented as mean ± s.e.m.
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lacked IL-7Ra did not alter the levels of intracellular ROS upon IL-7 culture (Figure 1d ).
IL-7-mediated T-ALL cell survival requires upregulation of ROS via NADPH oxidase complex and the respiratory chain
We next investigated the impact of ROS on IL-7-mediated T-ALL cell survival using the ROS scavengers bME and PDTC. First, we confirmed that the increase in ROS levels in T-ALL cells cultured with IL-7 was abrogated by addition of bME and PDTC (Figures 2a and b and Supplementary Figure S1A ). We then examined whether IL-7-mediated T-ALL cell viability was dependent on ROS generation. bME completely abrogated IL-7-mediated maintenance of mitochondrial membrane potential ( Figure 2c ) and inhibited the viability of IL-7-cultured T-ALL cells, as determined by FSC Â SSC discrimination ( Figure 2d ) and annexin V-FITC/PI staining ( Figure 2e ). Similarly, PDTC Figure 2 Mitochondrial respiration-and NADPH oxidase-dependent ROS upregulation is mandatory for IL-7-mediated T-ALL cell viability. TAIL7 cells (b-d, f, g) and primary T-ALL samples (a, e) were cultured for 72 h with or without IL-7 (10 ng/ml) either alone or plus 500 mM bME (a-e), 10 mM apocynin (f, g) or 50 nM rotenone (f, g). (a, b) Effect of bME on IL-7-mediated ROS upregulation. Cells were stained with the redox sensitive dye dichlorofluorescein diacetate and intracellular ROS levels were expressed as MIF within the live population. (b) Intracellular ROS levels in each indicated condition were normalized to medium alone and presented as mean ± s.e.m. of seven independent experiments. (c-e) Effect of bME on IL-7-mediated T-ALL cell survival. (c) Mitochondrial membrane potential was assessed using the lipophilic dye tetramethylrhodamine ethyl ester perchlorate and expressed as the MIF of the total population. Viability was determined by FSC Â SSC discrimination 
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A Silva et al treatment completely prevented IL-7-mediated T-ALL cell survival (Supplementary Figure S1B) . These results indicate that upregulation of intracellular ROS is critical for IL-7-mediated survival of T-ALL cells. Next, we sought to determine the cellular source of ROS upon IL-7 stimulation. The membrane-associated NADPH oxidase complex (NADPH/NADP þ ) and the mitochondrial electron respiratory chain are two major intracellular sources of ROS in the cell. Thus, we evaluated their role in modulating the levels of intracellular ROS in T-ALL cells stimulated with IL-7. Interestingly, both inhibition of the complex I of the respiratory chain with rotenone and disassembly of NADPH subunits with apocynin abrogated IL-7-mediated elevation of intracellular ROS levels (Figure 2f ). We then evaluated their impact on leukemia cell survival after IL-7 stimulation and found that both inhibitors abrogated IL-7-mediated viability of T-ALL cells (Figure 2g ). These results suggest that NADPH oxidase complex and the respiratory chain are involved in the IL-7-mediated generation of intracellular ROS that are crucial for the viability of leukemic cells.
Addition of exogenous H 2 O 2 is not sufficient to promote T-ALL cell viability
To evaluate whether exogenous ROS could mimic IL-7 stimulation in T-ALL cells, we treated TAIL7 cells with increasing doses of H 2 O 2 , using steady-state delivery 19 and assessed viability at 48 h of culture. Our data revealed that exogenous addition of H 2 O 2 was not sufficient to promote T-ALL cell viability and it induced apoptosis at higher doses (Supplementary Figure S2A) .
To understand the discrepancy between H 2 O 2 and IL-7 treatment on T-ALL cell viability, we compared the signaling pathways activated by each stimulus. Phosphorylation of Akt at S473, necessary for Akt full activation, occurred within 15 min both with H 2 O 2 and IL-7 stimulation (Supplementary Figure  S2B) . Also, GSK3 and FOXOs, which are direct Akt targets, were phosphorylated by both stimuli (Supplementary Figure S2B) , indicating that H 2 O 2 is able to efficiently lead to PI3K/Akt pathway activation. In contrast, H 2 O 2 failed to mimic IL-7 in activating STAT5 in TAIL7 cells (Supplementary Figure S2B) . H 2 O 2 has been described as an activator of stress-activated mitogen-activated protein kinases. 23 In accordance, we found that H 2 O 2 , but not IL-7, resulted in the activation of the proapoptotic signaling molecule c-Jun N-terminal kinase (Supplementary Figure S2B) . Surprisingly, c-Jun N-terminal kinase inhibition potentiated H 2 O 2 -induced cell death rather than preventing it (Supplementary Figures S3A, B) , in a similar manner to the effect of PI3K blockade (Supplementary Figure S2B) . However, we found that inhibition of lysosomal disruption using desferrioxamine significantly reversed H 2 O 2 -induced TAIL7 cell death (Supplementary Figure S3C) . These results are consistent with previous studies 24 and indicate that lysosomal disruption, rather than the stress-activated c-Jun N-terminal kinase pathway, is involved in promoting T-ALL cell death upon bolus H 2 O 2 stimulation. More importantly, our data suggest that although ROS are essential for IL-7-mediated survival of T-ALL cells, addition of exogenous H 2 O 2 per se is insufficient to mimic the pro-survival effects of IL-7.
IL-7 activates PI3K/Akt signaling pathway in a ROS-dependent manner
Activation of PI3K/Akt signaling pathway is mandatory for IL-7-mediated viability of T-ALL cells. 5 As H 2 O 2 was able to promote Akt phosphorylation, we next asked whether ROS contributed to IL-7-dependent T-ALL cell viability via regulation of PI3K/Akt signaling. Pre-treatment of TAIL7 cells with bME or PDTC (Figure 3a and Supplementary Figure S1C ) abrogated IL-7-dependent phosphorylation of Akt. In contrast, STAT5 phosphorylation was not affected (Figure 3a) . Thus, IL-7-dependent Akt phosphorylation appears to selectively require the participation of ROS in T-ALL cells. However, short-term stimulation IL-7 failed to upregulate the endogenous levels of ROS (Figure 3b ). This may hint that there is minor, localized, upregulation of ROS at the cell membrane 25, 26 upon IL-7 stimulation, which is sufficient to promote Akt phosphorylation but insufficient to be detected by dichlorofluorescein diacetate. Alternatively, although less likely, there could be a recruitment of ROS towards the cytoplasmic membrane without an overall increase in ROS levels. 
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To identify the source of ROS required for IL-7-dependent PI3K/Akt pathway activation, we pre-treated T-ALL cells with rotenone or apocynin. Inhibition of mitochondrial respiration, but not NADPH complex blockade, completely abrogated IL-7-mediated Akt phosphorylation (Figure 3c ). This suggests that, whereas both mechanisms are interconnected in drivingsustained IL-7-mediated ROS upregulation in leukemia T-cells (Figure 2) , only the ROS generated by mitochondrial respiration appear to be required for early PI3K/Akt signaling pathway activation upon IL-7 stimulation.
IL-7-mediated upregulation of ROS is PI3K/Akt/mTORand Glut-dependent
Previous studies demonstrated that constitutive activation of PI3K-mediated signaling in leukemia cells leads to the upregulation of endogenous ROS. 8 Significantly, the PI3K/Akt pathway downstream target mTOR, which is activated by IL-7 in T-ALL cells (Supplementary Figure S4) was also implicated in ROS generation. 8 Hence, we asked whether IL-7-mediated activation of the PI3K/Akt/mTOR axis could contribute to ROS sustained upregulation in T-ALL cells. TAIL7 cells were cultured for 72 h in the presence or absence of IL-7, with or without the PI3K specific inhibitor LY294002 and the mTOR specific inhibitor rapamycin. Inhibition of PI3K/Akt/mTOR signaling pathway, using LY294002 or rapamycin, completely abrogated IL-7-mediated elevation of intracellular ROS levels in TAIL7 (Figure 4a and Supplementary Figure S5A ) and primary T-ALL (Figure 4b and Supplementary Figure S5B) cells. These results suggest the existence of a positive interplay between ROS and PI3K/Akt/mTOR pathway within the context of IL-7-mediated signaling in T-ALL, in which ROS are required for full activation of PI3K-dependent signaling and, subsequently, 
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A Silva et al PI3K/Akt/mTOR pathway activity is critical for the sustained upregulation of ROS. We next sought to dissect how increased IL-7-mediated PI3K/ Akt/mTOR pathway activation might lead to upregulation of ROS in T-ALL cells. Intracellular ROS are a consequence of augmented cellular metabolism, 8 including glucose metabolism. IL-7 increases the expression of the glucose transporter Glut1 in a PI3K-dependent manner, providing the machinery for nutrient use by both normal and malignant T-cells. 5, 8, 27 Thus, we asked whether glucose transporter activity would regulate IL-7-mediated increase in intracellular ROS. TAIL7 cells were analyzed for ROS levels and viability by flow cytometry after 72 h of culture with IL-7 and 50 mM of the glucose transporter specific inhibitor, phloretin. Abrogation of Glut function prevented IL-7-mediated increase in intracellular ROS (Figure 4c ) and in the percentage of viable cells (Figure 4d ). These results suggest that glucose transporter activity is critical for IL-7-mediated upregulation of intracellular ROS levels in T-ALL cells.
Discussion
Despite the increasing awareness of the importance of studying the interplay between the cancer cell and the full spectrum of elements that constitute the malignant milieu, the current knowledge about the contribution of microenvironmental factors to tumor formation and progression is still far from complete. IL-7 has a critical role in T-ALL cell cycle progression and survival in vitro by inducing the activation of PI3K/Akt/mTOR signaling pathway and regulating the expression of p27 kip1 and Bcl-2. 3,5 Here, we further explored how IL-7 contributes to T-ALL cell survival in vitro by dissecting the interplay between the PI3K/Akt/mTOR axis and intracellular ROS.
ROS levels can be upregulated in malignant cells as a consequence of cell-autonomous alterations. 8, 28 ROS can also be formed in normal and malignant cells after a variety of extracellular stimuli. 13, 14 Interestingly, high oxidative state in hematopoietic cells can promote apoptosis 29 or viability.
14 Primary T-ALL cells display constitutively high ROS levels. 10 We now demonstrate that IL-7 further upregulates ROS levels without negatively impacting cell survival. On the contrary, ROS are mandatory for IL-7-mediated viability of T-ALL cells.
In contrast, exogenous H 2 O 2 stimulation did not prevent in vitro spontaneous apoptosis of T-ALL cells at low doses and even induced cell death at high doses. As H 2 O 2 is a small diffusible molecule, it is conceivable that exogenous administration will activate multiple signaling pathways 30 in ways that do not reproduce the involvement of ROS in IL-7-mediated signaling. This notwithstanding, our data indicate that the prosurvival effects of IL-7 were not mimicked by treatment with H 2 O 2 , and suggest that ROS are necessary but possibly insufficient to promote T-ALL cell survival.
Although we found that mitochondrial respiration is required for early Akt phosphorylation, our results argue against the existence of a rapid wave of ROS immediately upon IL-7 stimulation. The major increase in ROS levels observed after treatment of T-ALL cells with IL-7 appears to be a downstream consequence of IL-7-mediated signaling. However, one cannot exclude the possibility that dichlorofluorescein diacetate might not be sensitive enough to detect ROS upregulation in localized membrane microdomains. 25, 26 Also, it is conceivable that recruitment of ROS to defined microdomains, rather than upregulation of ROS, might rapidly occur on IL-7R triggering.
ROS generated/recruited through receptor activation will likely alter the redox state locally within specific cellular regions, 25, 26 therefore acting as second messengers by influencing the redox state and activation of signaling proteins. 11, 31 In fact, growth factors increase PIP3 levels not only by increasing PI3K activation, but also by inactivating a fraction of phosphatase and tensin homologue through endogenous production of cellular oxidants. 16, 32, 33 Our data suggest that PI3K and both the NADPH complex and the mitochondrial electron respiratory chain are associated with the sustained increase in ROS levels upon IL-7 stimulation of T-ALL cells. The NADPH oxidase complex (NADPH/NADP þ ) can be activated by PIP3-dependent signals, 34 and PI3K was shown to regulate the phosphorylation of the NADPH oxidase component p47 phox and the subsequent activation of NADPH oxidase complex. 35 Moreover, receptor tyrosine kinasemediated activation of PI3K results in the recruitment of p47 phox to the plasma membrane and consequent production of reactive oxygen species. 36 Mitochondrial respiration is the major cellular source of ROS. Under normal conditions, it is estimated that approximately 1-2% of the electrons leak out of mitochondrial electron transport chain, forming ROS, 37 and increased ROS levels associated with BCR-ABL transformation were linked to mitochondrial respiration. 8 In accordance, we found that the mitochondrial respiratory chain was necessary for IL-7-induced upregulation of ROS levels at late time points. Interestingly, the fact that both apocynin and rotenone alone were sufficient to completely prevent IL-7-mediated ROS upregulation and T-ALL cell viability suggests that NADPH complex and mitochondrial respiration may be intertwined in the context of IL-7 signaling, a possibility that is not unprecedented. [38] [39] [40] Glucose metabolism is regulated by glucose uptake, and in hematopoietic cells Glut1 is the primary source for intracellular glucose. 41 We previously reported that IL-7 induces Glut1 upregulation and glucose uptake in a PI3K-dependent manner in T-ALL cells. 5 In the present study, we found that the glucose transporter inhibitor phloretin leads to a reduction of IL-7 generated ROS, similar to that observed in cells treated with the PI3K and mTOR inhibitors. This suggests that the IL-7-dependent generation of ROS relies mainly on the supply of energy in the form of glucose or pyruvate, mediated by a PI3K/Akt/mTOR/Glut axis. This does not exclude the possibility that IL-7 can increase ROS levels in T-ALL cells via Akt-mediated phosphorylation and inhibition of FOXO transcription factors, which are critical negative regulators of oxidative stress. [42] [43] [44] Taking together our current and previously published data, 5 we propose a model (Supplementary Figure S6) , whereby IL-7 rapidly induces minor upregulation and/or recruitment of ROS that is required for early PI3K/Akt/mTOR signaling pathway activation in an NADPH oxidase-independent, mitochondrial respiration-reliant manner. In turn, PI3K/Akt/mTOR-mediated signaling leads to Glut1 upregulation and glucose uptake that are mandatory for late IL-7-mediated ROS upregulation. Interestingly, sustained elevation of ROS levels appears to rely on both NADPH oxidase and mitochondrial respiration. The crosstalk between PI3K pathway and ROS is crucial for IL-7-mediated viability of T-ALL cells. The involvement of ROS in both cell-intrinsic 10 and IL-7-mediated T-ALL cell survival suggests that antioxidants may represent promising tools for therapeutic intervention in this childhood malignancy.
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